Table 2.
Intervention groups | Pre-intervention urinary cotinine levels | Post-intervention urinary cotinine levels | Difference between pre- and post-intervention | |||||||
---|---|---|---|---|---|---|---|---|---|---|
L4 | L5 | L6 | L1 | L2 | L4 | L5 | L6 | Mean ± SD | Median (IQR) | |
Group one | 0 | 7 | 13 | 0 | 0 | 5 | 13 | 2 | 0.80 ± 0.6 | 1 (0–2) |
Group two | 0 | 12 | 8 | 1 | 0 | 4 | 13 | 2 | 0.70 ± 0.3 | 0 (0–4) |
Group three | 0 | 14 | 16 | 0 | 1 | 2 | 13 | 4 | 0.85 ± 0.3 | 1 (0–4) |
Number of subjects | 0 | 28 | 37 | 1 | 1 | 11 | 39 | 8 | Kruskal-Wallis ANOVA value (P value) | 6.08 (0.4) |
Percentage of subjects | 0 | 38 | 62 | 1.7 | 1.7 | 18.3 | 65 | 13.3 | ||
Chi-squared (P value) | 6.91 (0.032) | 6.27 (0.9) |
SD = standard deviation; IQR = interquartile range; 0 = no detectable level of tobacco use; L1 (10–30 ng/mL) and L2 (30–100 ng/mL) = no use of tobacco products; L3 (100–200ng/mL) = cut-off level and positive for tobacco use; L4 (200–500 ng/mL), L5 (500–1000ng/mL) and L6 (>1000ng/ml) = use of tobacco product; group one = laser group; group two = counselling group; group three = laser + counselling group; ANOVA = analysis of variance.